RESUMO
Introduction: Asthma is a common respiratory disease. Theophylline combined with inhaled corticosteroids (ICS) is a promising therapy for asthma. This study explored the therapeutic effects of ICS combined with theophylline on moderate and severe asthma patients and T lymphocyte subsets (CD3+CD8+ T cells) in peripheral blood. Material and methods: A total of 202 moderate and severe asthma patients were selected, with 101 treated with theophylline combined with ICS and 101 treated with ICS alone as controls. Lung function [forced expiratory volume within 1 second (FEV1), forced vital capacity (FVC), and peak expiratory flow (PEF)] were tested using a spirometer. Asthma symptom control was evaluated by asthma control tests (ACT). The life quality was evaluated using the Asthma Quality of Life Questionnaire (AQLQ). The number and percentage of CD3+ T, CD3+CD4+ T and CD3+CD8+ T cells in peripheral blood mononuclear cells were assessed by flow cytometry. The correlation between CD3+CD8+ T cells and lung function and asthma control of patients after combination therapy was analyzed by Pearson correlation analysis. Results: Compared with moderate and severe patients treated with ICS alone, theophylline improved the efficacy of ICS. Theophylline combined with ICS decreased IL-4 and IL-6 levels, and CD3+ T and CD3+CD8+ T cell number and percentage. After combined treatment, CD3+ CD8+ T cells in peripheral blood of patients were positively correlated with lung function and negatively correlated with asthma control. Conclusions: The additional use of theophylline improved the efficacy of corticosteroids in asthma patient treatment and reduced inflammation level and CD3+ T and CD3+CD8+ T cell contents in peripheral blood.
RESUMO
To investigate the effects of the surface markers B- and T-lymphocyte attenuator (BTLA) and B7 homologous body 4 (B7-H4) on expression of CD83, and Human Leukocyte Antigen-DR isotype (HLA-DR) that can activate dendritic cells (DCs). Flow cytometry was used to detect the co-expression of BTLA and B7-H4 on myeloid DCs (mDCs) in peripheral blood (PB) and pleural effusions (PE) in 15 volunteers and 20 tuberculous pleurisy (TP) patients. Co-expression of BTLA and B7-H4 (double positive (DP)) mDCs in PB and PE of TP patients were enhanced. The proportion of DP mDC in PB decreased markedly after 2 weeks treatment, but was still greater than in controls. Expression of CD83 and HLA-DR on DP mDCs was higher than on BTLA and B7-H4 double negative (DN) expressing mDCs in PB of different TP groups. Expression of CD83 on DP mDCs in PB and PE of TP patients was greater than that of controls. Expression of HLA-DR on DP mDCs in TP patient PB was lower than in TP PE and controls. In pleural tuberculosis (TB) patients, high expression of BTLA and B7-H4 promoted a high level of CD83 and HLA-DR, which had a negative regulatory effect on mDCs on anti-TB immunity.
Assuntos
Células Dendríticas/metabolismo , Imunidade Celular , Mycobacterium tuberculosis/imunologia , Receptores Imunológicos/biossíntese , Linfócitos T/imunologia , Tuberculose Pleural/metabolismo , Inibidor 1 da Ativação de Células T com Domínio V-Set/biossíntese , Adulto , Células Dendríticas/imunologia , Feminino , Citometria de Fluxo , Seguimentos , Humanos , Ativação Linfocitária/imunologia , Masculino , Mycobacterium tuberculosis/isolamento & purificação , Estudos Retrospectivos , Tuberculose Pleural/imunologia , Tuberculose Pleural/microbiologiaRESUMO
It has been reported that circular RNA (circRNA) is associated with human cancer. However, few studies have been reported in active pulmonary tuberculosis (APTB). The global circRNA expression was detected in the peripheral blood mononuclear cells (PBMCs) of APTB patients (n=5) and health controls (HC) (n=5) by using high-throughput sequencing. According to the systematical bioinformatics analysis, the basic content of circRNAs and their fold changes in the two groups were calculated. We selected 6 significant differentially expressed circRNAs, hsa_circ_0005836, hsa_circ_0009128, hsa_circ_0003519, hsa_circ_0023956, hsa_circ_0078768, and hsa_circ_0088452 and validated the expression in PBMCs from APTB (n=10) and HC (n=10) by real-time quantitative reverse transcription-polymerase chain reactions (qRT-PCRs). Further, the verification of these specific circRNAs (hsa_circ_0005836 and hsa_circ_0009128) between APTB (n=34) and HC (n=30) in PBMCs was also conducted by qRT-PCRs. The RNA-seq data showed the significant differential expression of the 523 circRNAs between the APTB and HC groups (199 circRNAs were significantly up-regulated and 324 circRNAs were down-regulated). Hsa_circ_0005836 and hsa_circ_0009128 expression was significantly down-regulated in the PBMCs of APTB (P<0.05) in the samples of APTB compared to HC in our study. The gene ontology based enrichment analysis of the circRNA-miRNA-mRNAs network showed that cellular catabolic process (P=7.10E-08), regulation of metabolic process (P=2.10E-06), catalytic activity (P=3.67E-08), protein binding (P=1.71E-07), cell part (P=3.46E-06), intracellular part (P=1.71E-07), and intracellular (P=3.67E-08) were recognized in the comparisons between APTB and HC. Based on KEGG analysis, HTLV-I infection, regulation of actin cytoskeleton, neurotrophin signaling pathway and mTOR signaling pathway were relevant during tuberculosis bacillus infection. We found for the first time that hsa_circ_0005836 and hsa_circ_0009128 were significantly down-regulated in the PBMCs of APTB compared with HC. Our findings indicate hsa_circ_0005836 might serve as a novel potential biomarker for TB infection.
Assuntos
Leucócitos Mononucleares/citologia , RNA/genética , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/genética , Citoesqueleto de Actina/metabolismo , Adolescente , Adulto , Idoso , Sequência de Bases , Feminino , Marcadores Genéticos/genética , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Masculino , Pessoa de Meia-Idade , Polissacarídeos/metabolismo , RNA/biossíntese , RNA Circular , Reação em Cadeia da Polimerase em Tempo Real , Análise de Sequência de RNA/métodos , Transdução de Sinais/genética , Serina-Treonina Quinases TOR/metabolismo , Adulto JovemRESUMO
Highly pathogenic avian influenza viruses (HPAIVs) cause severe disease in humans. There are no effective vaccines or antiviral therapies currently available to control fatal outbreaks due in part to the lack of understanding of virus-mediated immunopathology. In our study, we used hemagglutinin (HA) of H5N1 virus to investigate the related signaling pathways and their relationship to dysregulated innate immune reaction. We found the HA of H5N1 avian influenza triggered an abnormal innate immune signalling in the pulmonary epithelial cells, through an unusual process involving activation of Janus kinase 3 (JAK3) that is exclusively associated with γc chain and is essential for signaling via all γc cytokine receptors. By using a selective JAK3 inhibitor and JAK3 knockout mice, we have, for the first time, demonstrated the ability to target active JAK3 to counteract injury to the lungs and protect immunocytes from acute hypercytokinemia -induced destruction following the challenge of H5N1 HA in vitro and in vivo. On the basis of the present data, it appears that the efficacy of selective JAK3 inhibition is likely based on its ability to block multiple cytokines and protect against a superinflammatory response to pathogen-associated molecular patterns (PAMPs) attack. Our findings highlight the potential value of selective JAK3 inhibitor in treating the fatal immunopathology caused by H5N1 challenge.
Assuntos
Hemaglutininas/imunologia , Imunidade Inata/efeitos dos fármacos , Virus da Influenza A Subtipo H5N1/imunologia , Janus Quinase 3/metabolismo , Animais , Citocinas , Células Epiteliais/virologia , Hemaglutininas/farmacologia , Pulmão/virologia , Camundongos , Camundongos Knockout , Transdução de Sinais/imunologiaRESUMO
Protein-protein interactions have been studied extensively by green fluorescent protein-based fluorescence resonance energy transfer (FRET). The fluorescent proteins (FP) can be fused either to the N- or C-terminus of a host protein, but it is difficult to predict which order will perturb the host protein the least and provide the largest FRET. Therefore, a researcher needs to fuse host proteins with FP at both the N- and C-termini and test every possible combination (N-N, N-C, or C-C) to promote the energy transfer efficiency. Consequently, researchers required to do many subclonings. Herein, we designed FRET vectors to make them more efficient. The expression vectors of pCFP-YFP and pYFP-CFP were constructed with both cyan fluorescent protein (CFP)-yellow fluorescent protein (YFP) and YFP-CFP coding sequences flanked by two restriction enzyme sites, and with multiple cloning regions in the middle of both coding sequences. To select an optimal combination for FRET detection, we created plasmids encoding various fusion proteins of FP and signal transducers and activators of transcription 1 (STAT1) . We found that the nuclear:cytoplasmic fluorescence intensity ratios of STAT1-FP were significantly higher than those of FP-STAT1 at steady state, and fluorescence redistribution was only observed for STAT1-FP upon interferon gamma (IFNgamma) stimulation. In addition, positive FRET signals were only detected in the C-C interactions of STAT1 homodimer. Taken together, these data indicate that fusing STAT1 at the N-terminus with FP impairs the interactions of unphosphorylated STAT1 homodimers and possibly diminishes its binding with DNA. In contrast, STAT1-FP was functional with respect to its activation. Moreover, the FRET vectors are able to facilitate FRET studies.